Registration, insurance, and medical application of biotechnological drugs in Russia

dc.contributor.author	Ziganshina L.
dc.contributor.author	Niyazov R.
dc.contributor.author	Ziganshin A.
dc.date.accessioned	2018-09-18T20:27:47Z
dc.date.available	2018-09-18T20:27:47Z
dc.date.issued	2013
dc.identifier.issn	0091-150X
dc.identifier.uri	https://dspace.kpfu.ru/xmlui/handle/net/140143
dc.description.abstract	Existing approaches to the registration, insurance, and application of biotechnological drugs in Russia were analyzed using monoclonal antibody drugs and those produced using recombinant DNAtechnology as examples. Pharmacoeconomic aspects of using these drugs in the RF were described and compared with WHO recommendations for their use. © 2013 Springer Science+Business Media New York.
dc.relation.ispartofseries	Pharmaceutical Chemistry Journal
dc.subject	biotechnological drugs
dc.subject	drug provision
dc.subject	pharmacoeconomics
dc.title	Registration, insurance, and medical application of biotechnological drugs in Russia
dc.type	Article
dc.relation.ispartofseries-issue	11
dc.relation.ispartofseries-volume	46
dc.collection	Публикации сотрудников КФУ
dc.relation.startpage	693
dc.source.id	SCOPUS0091150X-2013-46-11-SID84879693673

Files in this item

Name: SCOPUS0091150X-20 ...

Size: 43.61Kb

Format: PDF

Публикации сотрудников КФУ Scopus [24551]
Коллекция содержит публикации сотрудников Казанского федерального (до 2010 года Казанского государственного) университета, проиндексированные в БД Scopus, начиная с 1970г.